Janus Henderson Group
ALPN

Janus Henderson Group’s Alpine Immune Sciences Inc ALPN Stock Holding History

Janus Henderson Group’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-450,827
Closed -$17.8M – 2605
2024
Q1 		$17.8M Sell
450,827
-132,412
-23% -$3.91M 0.01% 579
2023
Q4 		$11.1M Buy
+583,239
New +$8.1M 0.01% 650

Janus Henderson Group's ALPN Position: Q2 2024 in Review

Janus Henderson Group sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 450,827 shares — an estimated $17.8M sold.

Janus Henderson Group first reported a position in ALPN in Q4 2023 and held it in 2 quarters. The position peaked at $17.8M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

  • Janus Henderson Group reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
  • Janus Henderson Group sold 450,827 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $17.8M.
  • Janus Henderson Group first reported a position in Alpine Immune Sciences Inc in Q4 2023 and held it in 2 quarters.
  • Janus Henderson Group's Alpine Immune Sciences Inc position peaked at $17.8M in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Janus Henderson Group's 13F filing for Q2 2024, filed 14 Aug 2024.